|The National MPS Society is pleased to bring a special opportunity to our supporters who develop and administer clinical trials.|
This year, at the WORLDSymposium, a panel of experts in neurocognition held a special session to discuss the urgent need to develop and implement precise metrics for quantitating change in children with lysosomal and other neurological diseases. “Precision Metrics for Cognitive and Adaptive Measures in Clinical Trials” featured an explanation and rationale for using growth scale values (GSVs) to measure longitudinal cognitive and adaptive changes in early onset and severe neurological diseases. These scores are available for tests that are widely used in clinical trials such as the Bayley and the Vineland.
We know this topic is important to your work. To facilitate a wider dissemination of the symposium we are hosting a live follow-up Q&A session with the panel on March 17, Noon, EST. Registering for this webinar will allow you access to the symposium recordings.
Clinical trial development could not happen without the strong partnership between academia and industry. To support this collaboration, there is no cost to attend or to access the recordings.
Click to register, and please feel free to share with others on your team who may be interested.
Terri Klein, MPA
President & CEO
National MPS Society
If you are interested but can not attend the live webinar, register and we will send you a link to the recording.